Biology Newsfeed

New incentives needed to develop antibiotics to fight superbugs

Reuters: Science - Posted: May 29th, 2016, 7:04am UTC

NEW YORK (Reuters) - Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial incentives to make the effort worth the investment, companies and industry experts said.div class="feedflare" a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=6FhqCNjAGN4:QMbWBN1Y8SQ:yIl2AUoC8zA"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?d=yIl2AUoC8zA" border="0"/img/a a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=6FhqCNjAGN4:QMbWBN1Y8SQ:F7zBnMyn0Lo"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?i=6FhqCNjAGN4:QMbWBN1Y8SQ:F7zBnMyn0Lo" border="0"/img/a a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=6FhqCNjAGN4:QMbWBN1Y8SQ:V_sGLiPBpWU"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?i=6FhqCNjAGN4:QMbWBN1Y8SQ:V_sGLiPBpWU" border="0"/img/a /divimg src="http://feeds.feedburner.com/~r/reuters/scienceNews/~4/6FhqCNjAGN4" height="1" width="1" alt=""/

Read more

Return to the Newsfeed